JP Morgan Chase
HOWL icon

JP Morgan Chase’s Werewolf Therapeutics HOWL Stock Holding History

JP Morgan Chase’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67K Buy
2,096
+24
+1% +$16 ﹤0.01% 7048
2025
Q4 		$1.31K Buy
2,072
+949
+85% +$1.15K ﹤0.01% 6998
2025
Q3 		$2.21K Sell
1,123
-9,775
-90% -$13.4K ﹤0.01% 6894
2025
Q2 		$11.9K Sell
10,898
-5,114
-32% -$5.26K ﹤0.01% 6279
2025
Q1 		$15.6K Sell
16,012
-46,916
-75% -$61.4K ﹤0.01% 6215
2024
Q4 		$93.1K Buy
62,928
+49,608
+372% +$101K ﹤0.01% 5786
2024
Q3 		$28.2K Buy
13,320
+245
+2% +$557 ﹤0.01% 6158
2024
Q2 		$31.9K Sell
13,075
-58,109
-82% -$279K ﹤0.01% 6021
2024
Q1 		$461K Buy
71,184
+71,101
+85,664% +$414K ﹤0.01% 4851
2023
Q4 		$320 Sell
83
-665
-89% -$1.7K ﹤0.01% 6996
2023
Q3 		$1.6K Hold
748
– – ﹤0.01% 6579
2023
Q2 		$2.28K Hold
748
– – ﹤0.01% 6313
2023
Q1 		$2K Hold
748
– – ﹤0.01% 6420
2022
Q4 		$2K Sell
748
-752
-50% -$1.97K ﹤0.01% 6312
2022
Q3 		$7K Sell
1,500
-2,198
-59% -$11.9K ﹤0.01% 6026
2022
Q2 		$15K Sell
3,698
-11,929
-76% -$54.4K ﹤0.01% 5951
2022
Q1 		$68K Sell
15,627
-12,430
-44% -$87.1K ﹤0.01% 5673
2021
Q4 		$334K Buy
28,057
+24,209
+629% +$365K ﹤0.01% 5068
2021
Q3 		$66K Sell
3,848
-5,504
-59% -$93.9K ﹤0.01% 5744
2021
Q2 		$163K Buy
+9,352
New +$128K ﹤0.01% 5338

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's HOWL Position: Q1 2026 in Review

JP Morgan Chase increased its Werewolf Therapeutics (HOWL) stake by 1.2% in Q1 2026, buying an estimated $16 and bringing the position to 2,096 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #7048.

JP Morgan Chase first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $461K in Q1 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • JP Morgan Chase held 2,096 shares of Werewolf Therapeutics worth $1.67K as of Q1 2026.
  • JP Morgan Chase bought 24 Werewolf Therapeutics shares in Q1 2026, an estimated $16.
  • Werewolf Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7048 holding.
  • JP Morgan Chase first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Werewolf Therapeutics position peaked at $461K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.